
Taqui Khaja DO
@taquikhaja
Transplant & General Nephrologist w/ Renal Specialist of Houston| Transplant Nephrology alumni at @HMHNephrology| @NephBCM Alumni | @KUInternalMed alumni |
ID: 1150614733495701509
15-07-2019 03:55:04
1,1K Tweet
869 Followers
1,1K Following












🎉 Thrilled to share our commentary in Kidney International Reports ✅Is it time to expand the use of SGLT2 inhibitors in KTRs? ▶️Read on kireports.org/article/S2468-… Kidney International @KIReport Int Society of Nephrology Women in Nephrology-India Urmila Anandh ISN Education Dr Prof Manisha Sahay manjusha yadla





“Remembering pancreas transplantation as an option for patients with diabetes” A rather great one too! American Journal of Transplantation AJT Editorial Fellows Kidney Pancreas Community of Practice - AST amjtransplant.org/article/S1600-…

AKI in Cirrhosis: Management (based on etiology) from Kevin R. Regner, MD, MS, FASN #Nephpearls #NKFClinicals 🇺🇸


CONFIDENCE: Finerenone with Empagliflozin in CKD and T2D from NEJM Rajiv Agarwal MD, MS Peter Rossing Hiddo Heerspink #ERA25 🇦🇹 #Nephpearls 📌 Among persons with both CKD and T2D, initial therapy with finerenone plus empagliflozin led to a greater reduction in the urinary


Optimizing the timing and sequencing of guideline-directed medical therapy for T2D and CKD ca. 2024 from Brendon Neuen Katherine Tuttle george bakris George Bakris Muthu Vaduganathan #ERA25 🇦🇹 #Nephpearls #Cardiorenal 👉 pubmed.ncbi.nlm.nih.gov/40179265/
